|
6.11.2017 |
EN |
Official Journal of the European Union |
C 374/26 |
Judgment of the General Court of 21 September 2017 — Novartis v EUIPO — Meda (Zymara)
(Case T-214/15) (1)
((EU trade mark - Opposition proceedings - Application for the EU word mark Zymara - Earlier EU word mark FEMARA - Relative ground for refusal - Article 8(1)(b) of Regulation (EC) No 207/2009 - Article 75 of Regulation No 207/2009 - Article 76(1) of Regulation No 207/2009))
(2017/C 374/39)
Language of the case: English
Parties
Applicant: Novartis AG (Basle, Switzerland) (represented by M. Douglas, lawyer)
Defendant: European Union Intellectual Property Office (represented by H. O’Neill, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO: Meda AB (Solna, Sweden)
Re:
Action brought against the decision of the Fifth Board of Appeal of EUIPO of 6 February 2015 (Case R 550/2014-5) relating to opposition proceedings between Novartis and Meda.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Novartis AG to pay the costs. |